11
Views
0
CrossRef citations to date
0
Altmetric
Research Article

ICAM-1 is crucial for protection from TMEV-induced neuronal damage but not demyelination

Pages 452-458 | Published online: 10 Jul 2009

References

  • Cash E, Bandeir a A (1991). Effector T lymphocytes present in demyelinating lesions induced by Theiler's virus. Viral Immunol 4: 53–57.
  • Cash E, Bandeir a A, Chirinian S, Brahic M (1989). Charac-terization of B lymphocytes present in the demyelinat-ing lesions induced by Theiler's virus. J Immunol 143: 984–988.
  • Dal Canto MC, Lipton HL (1982). Ultrastructural immuno-histochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am J Pat hol 106: 20–29.
  • Drescher KM, Murray PD, David CS, Pease LR, Rodriguez M (1999). CNS cell populations are protected from virus-induced pathology by distinct arms of the immune sys-tem. Brain Pathol 9: 21–31.
  • Drescher KM, Nguyen LT, Tanej a V, Coenen MJ, Leibowitz JL, Strauss G, Hammerling GJ, David CS, Rodriguez M (1998). Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis. J Clin Invest 101: 1765–1774.
  • Drescher KM, Whittum-Hudson JA (1996). Modulation of immune-associated surface markers and cytokine pro-duction by murine retinal glial cells. J Neuroimmunol 64: 71–81.
  • Drescher KM, Zoecklein L, Pavelko KD, Rivera-Quinones C, Hollenbaugh D, Rodriguez M (2000). CD4OL is critical for protection from demyelinating disease and development of spontaneous remyelination in a mouse model of multiple sclerosis. Brain Pat ho] 10: 1–15.
  • Favre N, DaLaperousaz C, Ryffel B, Weiss NA, Imhof BA, Rudin W, Lucas R, Piguet PF (1999). Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect 1: 961–968.
  • Fiette L, Aubert C, Brahic M, Rossi CP (1993). Theiler's virus infection of beta 2-microglobulin-deficient mice. J Virol 67: 589–592.
  • Fiette L, Aubert C, Muller U, Huang S, Auget M, Brahic M, Bureau JF (1995). Theiler's virus infection of 129 Sv mice that lack the interferon a/13 or interferon y receptors. J Exp Med 181: 2069–2076.
  • Fiette L, Brahic M, Pena-Rossi C (1996). Infection of class-II deficient mice by the DA strain of Theiler's virus. J Virol 70: 4811–4815.
  • Hery C, Sebire G, Peudenier S, Tardieu M (1995). Adhesion to human neurons and astrocytes of monocytes: The role of interaction of CR3 and ICAM-1 and modulation by cytokines. J Neuroimmunol 57: 101–109.
  • Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M (1993). Immune response in mice that lack the interferon-y receptor. Science 259: 1742–1745.
  • Kraus J, Oschmann P, Engelhardt B, Schiel C, Hornig C, Bauer R, Kern A, Traupe H, Dorndorf W (1998). Soluble and cell surface ICAM-1 as markers for disease activ-ity in multiple sclerosis. Acta Neurol (Scand) 98: 102–109.
  • Kyrkanides S, Olschowka JA, Williams JP, Hansen JT, O'Banion MK (1999). TNF-a and IL-1,6 mediate inter-cellular adhesion molecule-1 induction via microglia-astrocyte interaction in CNS radiation injury. J Neuroim-munol 95: 95–106.
  • Lipton HL (1975). Theiler's virus infection in mice: An unusual biphasic disease process leading to demyeli-nation. Infect Immun 11: 1147–1155.
  • Lipton HL, Dal Canto MC (1976). Theiler's virus-induced demyelination: Prevention by immunosuppression. Science 192: 62–64.
  • Lipton HL, Dal Canto MC (1979). Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect Immun 26: 369–374.
  • McDonnell GV, McMillan SA, Douglas JP, Droogan AG, Hawkins SA (1999). Serum soluble adhesion molecules in multiple sclerosis: Raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease. J Neurol 246: 87–92.
  • Mycko MP, Kwinkowski M, Tronczynska E, Szymanska B, Selmaj KW (1998). Multiple sclerosis: The increased fre-quency of the ICAM-1 exon 6 gene point mutation ge-netic type K469. Ann Neurol 44: 70–75.
  • Njenga MK, Pavelko KD, Baisch J, Lin X, David C, Leibowitz J, Rodriguez M (1996). Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. I Virol 70: 1729–1737.
  • Patick AK, Pease LR, David CS, Rodriguez M (1990). Ma-jor histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inher-ited as a dominant trait in B10 congenic mice. I Virol 64: 5570–5576.
  • Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahhinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW (1993). Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock yet succumb to L. monocytogenes infection. Cell 73: 457–467.
  • Pierce ML, Rodriguez M (1989). Erichrome stain for myelin on osmicated tissue embedded in glycol methacrylate plastic. JHistotech 12: 35.
  • Raine CS, Cannella B (1992). Adhesion molecules and cen-tral nervous system inflammation. Sem Immunol 4:201–211.
  • Reiss Y, Engelhardt B (1999). T cell interaction with ICAM-1-deficient endothelium in vitro: Transendothelial mi-gration of different T cell populations is mediated by ICAM-1 and ICAM-2. Int Immunol 11: 1527–1539.
  • Rodriguez M, Kenny JJ, Thiemann RL, Woloschak GE (1990a). Theiler's virus-induced demyelination in mice immunosuppressed with anti-IgM and in mice express-ing the xid gene. Microb Pathog 8: 23–35.
  • Rodriguez M, Lafuse W, Leibowitz J, David CS (1986). Par-tial suppression of Theiler's virus-induced demyelina-tion in vivo by administration of monoclonal antibod-ies to immune response gene products (Ia antigens). Neurology 36: 964–970.
  • Rodriguez M, Lucchinetti CF, Clark RJ, Yaksh TL, Markowitz H, Lennon VA (1988). Immunoglobulins and complement in demyelination induced in mice by Theiler's virus. Jimmunol 140: 800–806.
  • Rodriguez M, Nickerson C, Patick AK, David CS (1991). Ex-pression of human HLA-B27 transgene alters suscepti- bility to murine Theiler's virus-induced demyelination. J Immunol 146: 2596–2602.
  • Rodriguez M, Patick AK, Pease LR (1990b). Abrogation of resistance to Theiler's virus-induced demyelination in C57BL mice by total body irradiation. I Neuroimmunol 26: 189–199.
  • Rodriguez M, Sriram S (1988). Successful therapy of TMEV-induced demyelination (DA strain) with monoclonal anti lyt2.2 antibody. J Immunol 140: 2950–2955.
  • Rose JW, Welsh CT, Hill KE, Houtchens MK, Fujinami RS, Townsend JJ (1999). Constrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalitis. I Neuroimmunol 97: 110–118.
  • Samoilova EB, Horton JL, Chen Y (1998). Experimental au-toimmune encephalomyelitis in intercellular adhesion molecule-1-deficient mice. Cell Immunol 190: 83–89.
  • Satoh J, Kastrukoff LF, Kim SU (1991). Cytokine-induced expression of intercellular adhesion molecule-1 (ICAM-1) in cultured human oligodendrocytes and astrocytes. J Neuropathol Exp Neurol 50: 215–226.
  • Shrikant P, Chung IY, Ballestas ME, Benveniste EN (1994). Regulation of intercellular adhesion molecule-1 gene ex-pression by tumor necrosis factor-a, interleukin-1,8, and interferon-y in astrocytes. J Neuroimm uno 1 51: 209–220.
  • Sligh JE, Ballantyne CM, Rich SS, Hawkins HK, Smith CW, Bradley A, Beaudet AL (1993). Inflammatory and im-mune responses are impaired in mice deficient in inter-cellular adhesion molecule-1. Proc Nat Acad Sci USA 90: 8529–8533.
  • Smith JP, Morris-Downes M, Brennan FR, Wallace GJ, Amor S (2000). A role for a4-integrin in the pathology follow-ing Semliki Forest virus infection. J Neuroimmunol 106: 60–68.
  • Sobel RA, Mitchell ME, Fondren G (1990). Intercellular ad-hesion molecule-1 (ICAM-1) in cellular immune reac-tions in the human central nervous system. Am J Pathol 136: 1309–1316.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.